Pasarin Guillermo MD is categorized under Neurologists in Fort Lauderdale, FL and active since 2001.
Pasarin Guillermo MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Guillermo Pasarin at the company’s single location by writing to 350 Nw 84th Avenue # 300, Fort Lauderdale, Florida FL 33324 or by phoning (954) 475-9244. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pasarin Guillermo MD |
| Contact Person: | Guillermo Pasarin |
| Address: | 350 Nw 84th Avenue # 300, Fort Lauderdale, Florida 33324 |
| Phone Number: | (954) 475-9244 |
| Website Address: | browardneurosurgery.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Neurologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Pasarin Guillermo MD was started in 2001 to provide professional Neurologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Guillermo Pasarin for inquiries that concern Pasarin Guillermo MD by calling the company number (954) 475-9244, as your correspondence is most welcome. Additionally, the physical location of the single location of Pasarin Guillermo MD can be found at the coordinates 26.12612,-80.26073 as well as the street address 350 Nw 84th Avenue # 300 in Fort Lauderdale, Florida 33324.
For its online presence, you may visit Pasarin Guillermo MD’s website at browardneurosurgery.com and engage with its social media outlets through on Twitter and on Facebook.